Jason Luke: Appreciated the interview with OncoDaily
Jason Luke, Associate Director for Clinical Research at Hillman Cancer Center, shared a post on X:
“Appreciated the interview with OncoDaily to discuss trends in cancer immunotherapy, my work, as well as role of professional societies and mentorship in career development. Focus on something you are passionate about, find great mentors and grind! Happy holidays!”
More posts featuring Jason Luke.
Dr. Jason J. Luke, MD, FACP, FASCO, is the Associate Director for Clinical Research at Hillman Cancer Center and Director of the Immunotherapy and Drug Development Center. He also serves as an Associate Professor of Medicine in the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine.
Dr. Luke specializes in early-phase drug development, particularly novel immunotherapeutics and biomarkers, with a focus on solid tumors and malignant melanoma. His clinical interests include Phase I trials, cancer immunotherapy, and drug development.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023